Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Inventory: 2014-2025

Historic Inventory for INNOVATE (VATE) over the last 7 years, with Sep 2025 value amounting to $18.1 million.

  • INNOVATE's Inventory fell 13.81% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year decrease of 13.81%. This contributed to the annual value of $20.8 million for FY2024, which is 7.14% down from last year.
  • Per INNOVATE's latest filing, its Inventory stood at $18.1 million for Q3 2025, which was down 12.56% from $20.7 million recorded in Q2 2025.
  • In the past 5 years, INNOVATE's Inventory registered a high of $22.4 million during Q4 2023, and its lowest value of $17.0 million during Q4 2021.
  • In the last 3 years, INNOVATE's Inventory had a median value of $20.8 million in 2024 and averaged $20.5 million.
  • In the last 5 years, INNOVATE's Inventory skyrocketed by 71.72% in 2021 and then decreased by 13.81% in 2025.
  • Quarterly analysis of 5 years shows INNOVATE's Inventory stood at $17.0 million in 2021, then rose by 11.18% to $18.9 million in 2022, then grew by 18.52% to $22.4 million in 2023, then decreased by 7.14% to $20.8 million in 2024, then decreased by 13.81% to $18.1 million in 2025.
  • Its Inventory stands at $18.1 million for Q3 2025, versus $20.7 million for Q2 2025 and $19.7 million for Q1 2025.